<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38495940</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Beyond acute infection: molecular mechanisms underpinning cardiovascular complications in long COVID.</ArticleTitle><Pagination><StartPage>1268571</StartPage><MedlinePgn>1268571</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1268571</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2024.1268571</ELocationID><Abstract><AbstractText>SARS-CoV-2, responsible for the global COVID-19 pandemic, has manifested significant cardiovascular implications for the infected population. These cardiovascular repercussions not only linger beyond the initial phase of illness but have also been observed in individuals who remain asymptomatic. This extended and pervasive impact is often called the post-acute COVID-19 syndrome (PACS) or "Long COVID". With the number of confirmed global cases approaching an alarming 756 million, the multifaceted challenges of Long COVID are undeniable. These challenges span from individual health complications to considerable burdens on worldwide healthcare systems. Our review comprehensively examines the complications of the persistent cardiovascular complications associated with COVID-19. Furthermore, we shed light on emerging therapeutic strategies that promise to manage and possibly mitigate these complications. We also introduce and discuss the profound concerns regarding the potential transgenerational repercussions of SARS-CoV-2, emphasizing the need for a proactive and informed approach to future research and clinical practice.</AbstractText><CopyrightInformation>&#xa9; 2024 Mostafa and Moustafa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Roba Hamed</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Systems Genomics Laboratory, American University in Cairo, New Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotechnology Graduate Program, American University in Cairo, New Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moustafa</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Systems Genomics Laboratory, American University in Cairo, New Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotechnology Graduate Program, American University in Cairo, New Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, American University in Cairo, New Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome (PACS)</Keyword><Keyword MajorTopicYN="N">transgenerational inheritance</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38495940</ArticleId><ArticleId IdType="pmc">PMC10942004</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2024.1268571</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. (2020) 94:44&#x2013;8. 10.1016/j.ijid.2020.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7102543</ArticleId><ArticleId IdType="pubmed">32171952</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. (2023). Available online at:
https://covid19.who.int/ (accessed July 25, 2023).</Citation></Reference><Reference><Citation>Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. (2020) 55(5):105951. 10.1016/j.ijantimicag.2020.105951</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105951</ArticleId><ArticleId IdType="pmc">PMC7139247</ArticleId><ArticleId IdType="pubmed">32234466</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. (2020) 26(4):450&#x2013;2. 10.1038/s41591-020-0820-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId><ArticleId IdType="pmc">PMC7095063</ArticleId><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. (2020) 17(9):543&#x2013;58. 10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant&#xf3;n-Pl&#xe1;garo C, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. (2020) 370(6518): 861&#x2013;5. 10.1126/science.abd3072</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, III, et al. COVID-19 and cardiovascular disease. Circ Res. (2021) 128:1214&#x2013;36. 10.1161/CIRCRESAHA.121.317997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JYY, Lin L-T, Bell R, Bruce JP, Richardson C, Pugh TJ, et al. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Sci Rep. (2021) 11(1):4533. 10.1038/s41598-021-83366-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83366-y</ArticleId><ArticleId IdType="pmc">PMC7907391</ArticleId><ArticleId IdType="pubmed">33633121</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. (2004) 363(9413):938&#x2013;47. 10.1016/S0140-6736(04)15788-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15788-7</ArticleId><ArticleId IdType="pmc">PMC7140173</ArticleId><ArticleId IdType="pubmed">15043961</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. (2002) 417(6891):822&#x2013;8. 10.1038/nature00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. (2004) 203(2):631&#x2013;7. 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, et al. The scRNA-Seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. Int J Environ Res Public Health. (2021) 18(1):284. 10.3390/ijerph18010284</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18010284</ArticleId><ArticleId IdType="pmc">PMC7794913</ArticleId><ArticleId IdType="pubmed">33401657</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med. (2020) 7:594495. 10.3389/fmed.2020.594495</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.594495</ArticleId><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. (2021) 27(1):28&#x2013;33. 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Yu F, Chang W, Zhang Y, Zhang L, Li P. Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology. Front Immunol. (2023) 14:1185233. 10.3389/fimmu.2023.1185233</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1185233</ArticleId><ArticleId IdType="pmc">PMC10213254</ArticleId><ArticleId IdType="pubmed">37251383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2 &#x2014; preliminary report. N Engl J Med. (2020) 383:1920&#x2013;31. 10.1056/NEJMoa2022483</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2022483</ArticleId><ArticleId IdType="pmc">PMC7377258</ArticleId><ArticleId IdType="pubmed">32663912</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. (2021) 594(7862):259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. (2020) 5(7):811&#x2013;8. 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh JD, Kitchen RR, Guseh JS, McNeill JN, Aid M, Martinot AJ, et al. Plasma proteomics of COVID-19-associated cardiovascular complications: implications for pathophysiology and therapeutics. JACC Basic Transl Sci. (2022) 7(5):425&#x2013;41. 10.1016/j.jacbts.2022.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2022.01.013</ArticleId><ArticleId IdType="pmc">PMC9067411</ArticleId><ArticleId IdType="pubmed">35530264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. (2020) 5(7):802&#x2013;10. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. (2020) 76(5):533&#x2013;46. 10.1016/j.jacc.2020.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. (2020) 38(7):1504&#x2013;7. 10.1016/j.ajem.2020.04.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Razavi AC, Kelly TN, He J, Fernandez C, Whelton PK, Krousel-Wood M, et al. Cardiovascular disease prevention and implications of coronavirus disease 2019: an evolving case study in the crescent city. J Am Heart Assoc. (2020) 9(13):e016997. 10.1161/JAHA.120.016997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.016997</ArticleId><ArticleId IdType="pmc">PMC7670499</ArticleId><ArticleId IdType="pubmed">32418463</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. (2020) 395(10237):1607&#x2013;8. 10.1016/S0140-6736(20)31094-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation. (2007) 116(25):2992&#x2013;3005. 10.1161/CIRCULATIONAHA.106.685206</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.685206</ArticleId><ArticleId IdType="pubmed">18086941</ArticleId></ArticleIdList></Reference><Reference><Citation>Arhontoulis DC, Kerr CM, Richards D, Tjen K, Hyams N, Jones JA, et al. Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries. J Tissue Eng Regen Med. (2022) 16(9):799&#x2013;811. 10.1002/term.3327</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.3327</ArticleId><ArticleId IdType="pmc">PMC9350263</ArticleId><ArticleId IdType="pubmed">35689600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Br&#xe4;uninger H, Aleshcheva G, Edler C, Meissner K, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. (2020) 5(11):1281&#x2013;5. 10.1001/jamacardio.2020.3551</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Frati P, Del Duca F, Santoro P, Manetti AC, La Russa R, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel, Switzerland). (2021) 11(9):1647. 10.3390/diagnostics11091647</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091647</ArticleId><ArticleId IdType="pmc">PMC8472043</ArticleId><ArticleId IdType="pubmed">34573988</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. (2020) 8(4):420&#x2013;2. 10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrah AA, Schwarskopf M, Wang ER, LaRocca T, Dhume A, Zhang S, et al. SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis. (2018) 23(1):79&#x2013;91. 10.1007/s10495-017-1438-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-017-1438-3</ArticleId><ArticleId IdType="pmc">PMC6019273</ArticleId><ArticleId IdType="pubmed">29236198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Gou J, Gao J, Huang L, Zhu Z, Ji S, et al. Immune characteristics of severe and critical COVID-19 patients. Signal Transduct Target Ther. (2020) 5(1):179. 10.1038/s41392-020-00296-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00296-3</ArticleId><ArticleId IdType="pmc">PMC7456639</ArticleId><ArticleId IdType="pubmed">32868756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanen PT, Vuorio A. SARS-CoV-2 reinfection: adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease. Atherosclerosis Plus. (2023) 53:1&#x2013;5. 10.1016/j.athplu.2023.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athplu.2023.06.002</ArticleId><ArticleId IdType="pmc">PMC10238112</ArticleId><ArticleId IdType="pubmed">37293388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangos M, Budde H, Kolijn D, Sieme M, Zhazykbayeva S, L&#xf3;di M, et al. SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress. Int J Cardiol. (2022) 362:196&#x2013;205. 10.1016/j.ijcard.2022.05.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.05.055</ArticleId><ArticleId IdType="pmc">PMC9132721</ArticleId><ArticleId IdType="pubmed">35643215</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe &#xc5;, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. (2021) 595(7865):107&#x2013;13. 10.1038/s41586-021-03570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. (2020) 383(6):590&#x2013;2. 10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustafa A, Khalel RS, Aziz RK. Traces of SARS-CoV-2 RNA in peripheral blood cells of patients with COVID-19. Omics: A Journal of Integrative Biology. (2021) 25(8):475&#x2013;83. 10.1089/omi.2021.0068</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2021.0068</ArticleId><ArticleId IdType="pmc">PMC8377512</ArticleId><ArticleId IdType="pubmed">34280038</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhu J, Yang L, Nilsson-Payant BE, Hurtado R, Lacko LA, et al. SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circ Res. (2022) 130(7):963&#x2013;77. 10.1161/CIRCRESAHA.121.320518</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.320518</ArticleId><ArticleId IdType="pmc">PMC8963443</ArticleId><ArticleId IdType="pubmed">35255712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J-Y, Wang G, Huang X, Lee H, Lee J-G, Yang P, et al. SARS-CoV-2 Nsp6 damages drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis. Commun Biol. (2022) 5(1):1039. 10.1038/s42003-022-03986-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03986-6</ArticleId><ArticleId IdType="pmc">PMC9523645</ArticleId><ArticleId IdType="pubmed">36180527</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul C, Amaral AP, Oskouei B, Hu M-C, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. (2011) 121(11):4393&#x2013;408. 10.1172/JCI46122</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI46122</ArticleId><ArticleId IdType="pmc">PMC3204831</ArticleId><ArticleId IdType="pubmed">21985788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Yang P, Fu D, Liu M, Deng X, Shao M, et al. The protective effect of allicin on myocardial ischemia-reperfusion by inhibition of ca overload-induced cardiomyocyte apoptosis via the PI3K/GRK2/PLC-&#x3b3;/IP3R signaling pathway. Aging. (2021) 13(15):19643&#x2013;56. 10.18632/aging.203375</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203375</ArticleId><ArticleId IdType="pmc">PMC8386544</ArticleId><ArticleId IdType="pubmed">34343971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao Y-H, Chen Y-C, Lin Y-K, Shiu R-J, Chao T-F, Chen S-A, et al. FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells. Eur J Clin Investig. (2014) 44(8):795&#x2013;801. 10.1111/eci.12296</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12296</ArticleId><ArticleId IdType="pubmed">24942561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TW, Chung CC, Lee TI, Lin YK, Kao YH, Chen YJ. Fibroblast growth factor 23 stimulates cardiac fibroblast activity through phospholipase C-mediated calcium signaling. Int J Mol Sci. (2021) 23(1):166. 10.3390/ijms23010166</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010166</ArticleId><ArticleId IdType="pmc">PMC8745152</ArticleId><ArticleId IdType="pubmed">35008591</ArticleId></ArticleIdList></Reference><Reference><Citation>Tominaga K, Suzuki HI. TGF-&#x3b2; signaling in cellular senescence and aging-related pathology. Int J Mol Sci. (2019) 20(20):5002. 10.3390/ijms20205002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205002</ArticleId><ArticleId IdType="pmc">PMC6834140</ArticleId><ArticleId IdType="pubmed">31658594</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur J Heart Fail. (2021) 23(3):468&#x2013;75. 10.1002/ejhf.2096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. (2001) 7(3):167&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">11581570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J Intern Med. (2021) 289(4):523&#x2013;31. 10.1111/joim.13178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13178</ArticleId><ArticleId IdType="pmc">PMC7536991</ArticleId><ArticleId IdType="pubmed">32976665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res. (2005) 11(4):225&#x2013;9. 10.1179/096805105X46565</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/096805105X46565</ArticleId><ArticleId IdType="pubmed">16176659</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts LM, Buford TW. Lipopolysaccharide binding protein is associated with CVD risk in older adults. Aging Clin Exp Res. (2021) 33(6):1651. 10.1007/s40520-020-01684-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01684-z</ArticleId><ArticleId IdType="pmc">PMC7937758</ArticleId><ArticleId IdType="pubmed">32895891</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. (2021) 9(2):129. 10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, et al. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res. (2022) 209:106&#x2013;14. 10.1016/j.thromres.2021.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.027</ArticleId><ArticleId IdType="pmc">PMC8642246</ArticleId><ArticleId IdType="pubmed">34922160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. Br Med J. (2021) 372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. Br Med J. (2021) 373:n1098. 10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28(3):583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PloS One. (2021) 16(7):e0254523. 10.1371/journal.pone.0254523</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Barbi V, Gottardi Zamperla M, Atlante S, Forleo L, Nesta M, et al. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci. (2021) 22:6151. 10.3390/ijms22116151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekaert S, De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Langlois M, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell. (2007) 6(5):639&#x2013;47. 10.1111/j.1474-9726.2007.00321.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2007.00321.x</ArticleId><ArticleId IdType="pubmed">17874998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng F, Luk AO, Tam CHT, Fan B, Wu H, Yang A, et al. Shortened relative leukocyte telomere length is associated with prevalent and incident cardiovascular complications in type 2 diabetes: analysis from the Hong Kong diabetes register. Diabetes Care. (2020) 43(9):2257&#x2013;65. 10.2337/dc20-0028</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0028</ArticleId><ArticleId IdType="pubmed">32661111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima T, Li TY, Mottis A, Auwerx J. Pleiotropic effects of mitochondria in aging. Nat Aging. (2022) 2(3):199&#x2013;213. 10.1038/s43587-022-00191-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00191-2</ArticleId><ArticleId IdType="pubmed">37118378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. (2021) 320(1):C57&#x2013;65. 10.1152/ajpcell.00426.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfatni A, Riou M, Charles A-L, Meyer A, Barnig C, Andres E, et al. Peripheral blood mononuclear cells and platelets mitochondrial dysfunction, oxidative stress, and circulating mtDNA in cardiovascular diseases. J Clin Med Res. (2020) 9(2):311. 10.3390/jcm9020311</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020311</ArticleId><ArticleId IdType="pmc">PMC7073649</ArticleId><ArticleId IdType="pubmed">31979097</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer F, Riou M, Charles A-L, Meyer A, Andres E, Geny B, et al. Pathophysiology of heart failure: a role for peripheral blood mononuclear cells mitochondrial dysfunction? J Clin Med Res. (2022) 11(3):741. 10.3390/jcm11030741</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030741</ArticleId><ArticleId IdType="pmc">PMC8836880</ArticleId><ArticleId IdType="pubmed">35160190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulasinghe A, Liu N, Tan CW, Monkman J, Sinclair JE, Bhuva DD, et al. Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage. Immunology. (2023) 168(3):403&#x2013;19. 10.1111/imm.13577</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13577</ArticleId><ArticleId IdType="pmc">PMC9537957</ArticleId><ArticleId IdType="pubmed">36107637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran K, Maity S, Muthukumar AR, Kandala S, Tomar D, Abd El-Aziz TM, et al. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience. (2022) 25(1):103722. 10.1016/j.isci.2021.103722</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8720045</ArticleId><ArticleId IdType="pubmed">35005527</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;nico P, Ostrosky-Wegman P, Salazar AM. The potential role of COVID-19 in the induction of DNA damage. Mutat Res Rev Mutat Res. (2022) 789:108411. 10.1016/j.mrrev.2022.108411</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2022.108411</ArticleId><ArticleId IdType="pmc">PMC8767986</ArticleId><ArticleId IdType="pubmed">35690420</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Szeto GL, Lemos MP, Czartoski JL, MacMillan H, et al. Persistent serum protein signatures define an inflammatory subset of long COVID. Nat Commun. (2023) 14:3417. 10.1038/s41467-023-38682-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Ren X, Yang Y, Xu B, Li Y, Feng Y, et al. An alternative way of SARS-COV-2 to induce cell stress and elevated DNA damage risk in cardiomyocytes without direct infection. Immun Inflamm Dis. (2022) 10(7):e638. 10.1002/iid3.638</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.638</ArticleId><ArticleId IdType="pmc">PMC9186334</ArticleId><ArticleId IdType="pubmed">35759228</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LH, Huang M, Fang SG, Liu DX. Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase &#x3b4;. J Biol Chem. (2011) 286(45):39546&#x2013;59. 10.1074/jbc.M111.242206</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.242206</ArticleId><ArticleId IdType="pmc">PMC3234778</ArticleId><ArticleId IdType="pubmed">21918226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395(10224):565&#x2013;74. 10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto FK. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J. (2020) 39(3):198&#x2013;216. 10.1007/s10930-020-09901-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09901-4</ArticleId><ArticleId IdType="pmc">PMC7245191</ArticleId><ArticleId IdType="pubmed">32447571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong S-W, Young BE, Wu K-X, Siau A, Krishnan S, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife. (2021) 10:e64909. 10.7554/eLife.64909</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka H, Morii T, Vogel T, Hornicek FJ, Weissbach L. Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro. Exp Cell Res. (2003) 287(1):166&#x2013;77. 10.1016/S0014-4827(03)00137-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-4827(03)00137-X</ArticleId><ArticleId IdType="pubmed">12799192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Xu Y, Zhang J, Ran X, Jia X, Wang J, et al. Longitudinal serum proteome characterization of COVID-19 patients with different severities revealed potential therapeutic strategies. Front Immunol. (2022) 13:893943. 10.3389/fimmu.2022.893943</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.893943</ArticleId><ArticleId IdType="pmc">PMC9361788</ArticleId><ArticleId IdType="pubmed">35958562</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi-Kolli M, Sadri Nahand J, Kiani SJ, Khanaliha K, Khatami A, Taghizadieh M, et al. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease. Braz J Infect Dis. (2022) 26(3):102354. 10.1016/j.bjid.2022.102354</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2022.102354</ArticleId><ArticleId IdType="pmc">PMC9035361</ArticleId><ArticleId IdType="pubmed">35500644</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao RY, Li Q, Miao Y, Zhang Y, Yuan W, Fan L, et al. The emerging role of MicroRNA-155 in cardiovascular diseases. BioMed Res Int. (2016) 2016:9869208. 10.1155/2016/9869208</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9869208</ArticleId><ArticleId IdType="pmc">PMC5149600</ArticleId><ArticleId IdType="pubmed">28018919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A. (2021) 118(21):e2105968118. 10.1073/pnas.2105968118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazachenka A, Kassiotis G. SARS-CoV-2-host chimeric RNA-Sequencing reads do not necessarily signify virus integration into the host DNA. Front Microbiol. (2021) 12:676693. 10.3389/fmicb.2021.676693</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.676693</ArticleId><ArticleId IdType="pmc">PMC8206523</ArticleId><ArticleId IdType="pubmed">34149667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, Chakravorty S, Mirabelli C, Wang L, Trujillo-Ochoa JL, Chauss D, et al. Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual. J Virol. (2021) 95:e0029421. 10.1128/JVI.00294-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00294-21</ArticleId><ArticleId IdType="pmc">PMC8274596</ArticleId><ArticleId IdType="pubmed">33980601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Liu X-Z, He X, Zhou L-Q. Exogenous coronavirus interacts with endogenous retrotransposon in human cells. Front Cell Infect Microbiol. (2021) 11:609160. 10.3389/fcimb.2021.609160</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.609160</ArticleId><ArticleId IdType="pmc">PMC7959850</ArticleId><ArticleId IdType="pubmed">33732659</ArticleId></ArticleIdList></Reference><Reference><Citation>Marston JL, Greenig M, Singh M, Bendall ML, Duarte RRR, Feschotte C, et al. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements. JCI Insight. (2021) 6(24):e147170. 10.1172/jci.insight.147170</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147170</ArticleId><ArticleId IdType="pmc">PMC8783694</ArticleId><ArticleId IdType="pubmed">34731091</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardelli M, Giacconi R, Malavolta M, Provinciali M. Endogenous retroelements in cellular senescence and related pathogenic processes: promising drug targets in age-related diseases. Curr Drug Targets. (2016) 17(4):416&#x2013;27. 10.2174/1389450116666150518095829</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450116666150518095829</ArticleId><ArticleId IdType="pubmed">25981608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafin RN, Khusnutdinova EK. COVID-19, retroelements, and aging. Adv Gerontol. (2021) 11(1):83&#x2013;92. 10.1134/S2079057021010458</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S2079057021010458</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B, Reynaud JM, Gourru-Lesimple G, Perron H, Marche PN, Horvat B. Induction of proinflammatory multiple sclerosis-associated retrovirus envelope protein by human herpesvirus-6A and CD46 receptor engagement. Front Immunol. (2018) 9:2803. 10.3389/fimmu.2018.02803</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02803</ArticleId><ArticleId IdType="pmc">PMC6291489</ArticleId><ArticleId IdType="pubmed">30574140</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B, Brunel J, Pierquin J, Iampietro M, Decimo D, Queruel N, et al. SARS-CoV-2 induces human endogenous retrovirus type W envelope protein expression in blood lymphocytes and in tissues of COVID-19 patients. iScience. (2023) 26:106604. 10.1016/j.isci.2023.106604</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106604</ArticleId><ArticleId IdType="pmc">PMC10079620</ArticleId><ArticleId IdType="pubmed">37091988</ArticleId></ArticleIdList></Reference><Reference><Citation>Duperray A, Barbe D, Raguenez G, Weksler BB, Romero IA, Couraud P-O, et al. Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4. Int Immunol. (2015) 27(11):545&#x2013;53. 10.1093/intimm/dxv025</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxv025</ArticleId><ArticleId IdType="pmc">PMC4625887</ArticleId><ArticleId IdType="pubmed">25957268</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Su Q, Zhang F, Tun HM, Mak JWY, Lui GC-Y, et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun. (2022) 13(1):6806. 10.1038/s41467-022-34535-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. (2021) 70(4):698&#x2013;706. 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. (2020) 159(3):944&#x2013;955.e8. 10.1053/j.gastro.2020.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. (2022) 71(3):544&#x2013;52. 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang J, Wang H, Xue X, Zhang S. Microbiota and COVID-19: long-term and complex influencing factors. Front Microbiol. (2022) 13:963488. 10.3389/fmicb.2022.963488</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.963488</ArticleId><ArticleId IdType="pmc">PMC9417543</ArticleId><ArticleId IdType="pubmed">36033885</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. (2017) 8(1):845. 10.1038/s41467-017-00900-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00900-1</ArticleId><ArticleId IdType="pmc">PMC5635030</ArticleId><ArticleId IdType="pubmed">29018189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Huda MN, Bennett BJ. Sequence meets function-microbiota and cardiovascular disease. Cardiovasc Res. (2022) 118(2):399&#x2013;412. 10.1093/cvr/cvab030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab030</ArticleId><ArticleId IdType="pmc">PMC8803075</ArticleId><ArticleId IdType="pubmed">33537709</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Li J, Liu H, Tang Y, Zhan Q, Lai W, et al. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease. Atherosclerosis. (2019) 284:121&#x2013;8. 10.1016/j.atherosclerosis.2018.11.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2018.11.038</ArticleId><ArticleId IdType="pubmed">30897381</ArticleId></ArticleIdList></Reference><Reference><Citation>Toya T, Corban MT, Marrietta E, Horwath IE, Lerman LO, Murray JA, et al. Coronary artery disease is associated with an altered gut microbiome composition. PloS One. (2020) 15(1):e0227147. 10.1371/journal.pone.0227147</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0227147</ArticleId><ArticleId IdType="pmc">PMC6988937</ArticleId><ArticleId IdType="pubmed">31995569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. (2015) 163(7):1585&#x2013;95. 10.1016/j.cell.2015.11.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.11.055</ArticleId><ArticleId IdType="pmc">PMC4871610</ArticleId><ArticleId IdType="pubmed">26687352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gim&#xe9;nez-Bastida JA, Gonz&#xe1;lez-Sarr&#xed;as A, Larrosa M, Tom&#xe1;s-Barber&#xe1;n F, Esp&#xed;n JC, Garc&#xed;a-Conesa M-T. Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-&#x3b1;-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res. (2012) 56(5):784&#x2013;96. 10.1002/mnfr.201100677</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201100677</ArticleId><ArticleId IdType="pubmed">22648625</ArticleId></ArticleIdList></Reference><Reference><Citation>Spigoni V, Mena P, Cito M, Fantuzzi F, Bonadonna RC, Brighenti F, et al. Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells. Molecules. (2016) 21(8):1009. 10.3390/molecules21081009</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21081009</ArticleId><ArticleId IdType="pmc">PMC6274502</ArticleId><ArticleId IdType="pubmed">27490528</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. (2018) 138(22):2486&#x2013;98. 10.1161/CIRCULATIONAHA.118.033714</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.033714</ArticleId><ArticleId IdType="pubmed">30571343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Wang Z. Gut microbiome and cardiovascular disease. Curr Opin Cardiol. (2020) 35(3):207&#x2013;18. 10.1097/HCO.0000000000000720</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000720</ArticleId><ArticleId IdType="pmc">PMC7442318</ArticleId><ArticleId IdType="pubmed">32068612</ArticleId></ArticleIdList></Reference><Reference><Citation>Musa SS, Bello UM, Zhao S, Abdullahi ZU, Lawan MA, He D. Vertical transmission of SARS-CoV-2: a systematic review of systematic reviews. Viruses. (2021) 13(9):1877. 10.3390/v13091877</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091877</ArticleId><ArticleId IdType="pmc">PMC8471858</ArticleId><ArticleId IdType="pubmed">34578458</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschetti R, Vivanti AJ, Vauloup-Fellous C, Loi B, Benachi A, De Luca D. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nat Commun. (2020) 11(1):5164. 10.1038/s41467-020-18982-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18982-9</ArticleId><ArticleId IdType="pmc">PMC7566441</ArticleId><ArticleId IdType="pubmed">33060565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents&#x2019; and grandparents&#x2019; slow growth period. Eur J Human Genet. (2002) 10(11):682&#x2013;8. 10.1038/sj.ejhg.5200859</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejhg.5200859</ArticleId><ArticleId IdType="pubmed">12404098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleeman EA, Gubert C, Hannan AJ. Transgenerational epigenetic impacts of parental infection on offspring health and disease susceptibility. Trends Genet. (2022) 38(7):662&#x2013;75. 10.1016/j.tig.2022.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2022.03.006</ArticleId><ArticleId IdType="pmc">PMC8992946</ArticleId><ArticleId IdType="pubmed">35410793</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti M-E. Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models. Cell Mol Life Sci. (2013) 70(9):1597&#x2013;608. 10.1007/s00018-013-1298-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1298-0</ArticleId><ArticleId IdType="pmc">PMC3625497</ArticleId><ArticleId IdType="pubmed">23435955</ArticleId></ArticleIdList></Reference><Reference><Citation>Conine CC, Sun F, Song L, Rivera-P&#xe9;rez JA, Rando OJ. Small RNAs gained during epididymal transit of sperm are essential for embryonic development in mice. Dev Cell. (2018) 46(4):470&#x2013;480.e3. 10.1016/j.devcel.2018.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2018.06.024</ArticleId><ArticleId IdType="pmc">PMC6103825</ArticleId><ArticleId IdType="pubmed">30057276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma U. Paternal contributions to offspring health: role of sperm small RNAs in intergenerational transmission of epigenetic information. Front Cell Dev Biol. (2019) 7:215. 10.3389/fcell.2019.00215</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00215</ArticleId><ArticleId IdType="pmc">PMC6803970</ArticleId><ArticleId IdType="pubmed">31681757</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyebji S, Hannan AJ, Tonkin CJ. Pathogenic infection in male mice changes sperm small RNA profiles and transgenerationally alters offspring behavior. Cell Rep. (2020) 31(4):107573. 10.1016/j.celrep.2020.107573</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107573</ArticleId><ArticleId IdType="pubmed">32348768</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner KD, Wagner N, Ghanbarian H, Grandjean V, Gounon P, Cuzin F, et al. RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse. Dev Cell. (2008) 14(6):962&#x2013;9. 10.1016/j.devcel.2008.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2008.03.009</ArticleId><ArticleId IdType="pubmed">18539123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Parikh S, Nissa MU, Acharjee A, Singh A, Patwa D, et al. Semen proteomics of COVID-19 convalescent men reveals disruption of key biological pathways relevant to male reproductive function. ACS Omega. (2022) 7:8601&#x2013;12. 10.1021/acsomega.1c06551</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.1c06551</ArticleId><ArticleId IdType="pmc">PMC8928495</ArticleId><ArticleId IdType="pubmed">35309488</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh Maleki B, Tartibian B. COVID-19 and male reproductive function: a prospective, longitudinal cohort study. Reproduction. (2021) 161(3):319&#x2013;31. 10.1530/REP-20-0382</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-20-0382</ArticleId><ArticleId IdType="pubmed">33522983</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbitskaia AD, Komarova EM, Milyutina YP, Ishchuk MA, Sagurova YM, Safaryan GK, et al. Oxidative stress markers and sperm DNA fragmentation in men recovered from COVID-19. Int J Mol Sci. (2022) 23(17):10060. 10.3390/ijms231710060</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231710060</ArticleId><ArticleId IdType="pmc">PMC9456229</ArticleId><ArticleId IdType="pubmed">36077455</ArticleId></ArticleIdList></Reference><Reference><Citation>Castiglione Morelli MA, Iuliano A, Schettini SCA, Ferri A, Colucci P, Viggiani L, et al. Are the follicular fluid characteristics of recovered coronavirus disease 2019 patients different from those of vaccinated women approaching fertilization? Front Physiol. (2022) 13:840109. 10.3389/fphys.2022.840109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.840109</ArticleId><ArticleId IdType="pmc">PMC8905595</ArticleId><ArticleId IdType="pubmed">35283772</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaratti MR, Macabelli CH, Augusto Neto JD, Grejo MP, Pandey AK, Perecin F, et al. Maternal transmission of mitochondrial diseases. Genet Mol Biol. (2020) 43(1 suppl. 1):e20190095. 10.1590/1678-4685-gmb-2019-0095</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-4685-gmb-2019-0095</ArticleId><ArticleId IdType="pmc">PMC7197987</ArticleId><ArticleId IdType="pubmed">32141474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabravolski SA, Khotina VA, Sukhorukov VN, Kalmykov VA, Mikhaleva LM, Orekhov AN. The role of mitochondrial DNA mutations in cardiovascular diseases. Int J Mol Sci. (2022) 23(2):952. 10.3390/ijms23020952</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020952</ArticleId><ArticleId IdType="pmc">PMC8778138</ArticleId><ArticleId IdType="pubmed">35055137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>